Sugar.fit to raise $10 mn in seed funding

  • Sugar.fit claims to hit $1 million annual recurring revenue this quarter and plans to expand to 10 cities over the next few months

Saumya Tewari
Published3 Sep 2021, 02:42 PM IST
Madan Somasundaram, co-founder, Sugar.fit
Madan Somasundaram, co-founder, Sugar.fit

Healthcare startup Sugar.fit on Friday said it is set to raise $10 million in seed funding from health and fitness firm Cure.fit along with early-stage venture capital fund Endiya Partners and Tanglin Venture. The investment is expected to close by September 2021.

Sugar.fit seeks to manage and reverse diabetes through a highly consumer-centric data-driven digital health experience. Launched two months ago with operations in Bengaluru and Delhi-NCR, the company claims to hit $1 million annual recurring revenue (ARR) this quarter. Sugar.fit plans to expand to 10 cities over the next few months.

Madan Somasundaram, co-founder of Sugar.fit said that 90% of our users are seeing a significant drop in their blood sugar levels along with drastic reduction in medication and weight and are on track for diabetes reversal.

"Our customers have rated the product 3.9 on a scale of 4 and we are seeing referrals from word-of-mouth every day. I am confident that Sugar.fit can sustainably manage and reverse diabetes for millions of Indians in the next few years," he added.

About 70 million people in India suffer from diabetes and another 80 million are pre-diabetic. The startup uses continuous glucose monitoring technology (CGM), which helps users see real-time impact of various food and lifestyle activities on their blood sugar level. Sugar.fit’s program further combines medical experts with technology, including coaching, personalised analytics, and integrated devices and testing.

Through this partnership, one of the investors Cure.fit will also actively support the Sugar.fit team with their fitness and wellness content, and access to their millions of health-conscious consumer base in the country.

Ramesh Byrapaneni, partner, Endiya Partners said that there is increasing evidence that with proper medical and lifestyle interventions, diabetes can be prevented, managed better and even reversed.

"However, current systems of care management are often generic and lack personalisation. Sugar.fit’s goal to sustainably manage and reverse diabetes for millions of Indians in the next few years is a worthy goal which we at Endiya are thrilled to partner in,” he added.

Sugar.fit’s founding team includes Madan Somasundaram and Shivtosh Kumar and the core founding team comes with vast experience in building and scaling products at Cure.fit, Dailyhunt, Flipkart, Myntra, Samsung etc. Majority of the tech team is from Cure.fit.

Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:3 Sep 2021, 02:42 PM IST
Business NewsCompaniesStart-upsSugar.fit to raise $10 mn in seed funding

Get Instant Loan up to ₹10 Lakh!

  • Employment Type

    Most Active Stocks

    Tata Steel share price

    149.70
    07:18 PM | 1 NOV 2024
    1.05 (0.71%)

    Indian Oil Corporation share price

    145.00
    07:19 PM | 1 NOV 2024
    2.3 (1.61%)

    Tata Power share price

    445.20
    07:19 PM | 1 NOV 2024
    5.15 (1.17%)

    Bandhan Bank share price

    183.65
    07:10 PM | 1 NOV 2024
    1.4 (0.77%)
    More Active Stocks

    Market Snapshot

    • Top Gainers
    • Top Losers
    • 52 Week High

    Rainbow Childrens Medicare share price

    1,545.00
    06:59 PM | 1 NOV 2024
    -67.25 (-4.17%)

    ICICI Securities share price

    833.45
    06:59 PM | 1 NOV 2024
    -32.85 (-3.79%)

    Vijaya Diagnostic Centre share price

    966.70
    06:59 PM | 1 NOV 2024
    -30.35 (-3.04%)

    Narayana Hrudayalaya share price

    1,235.60
    06:59 PM | 1 NOV 2024
    -36.75 (-2.89%)
    More from Top Losers

    Brigade Enterprises share price

    1,244.80
    07:19 PM | 1 NOV 2024
    71.75 (6.12%)

    PCBL share price

    432.15
    07:17 PM | 1 NOV 2024
    21.35 (5.2%)

    Piramal Pharma share price

    281.85
    07:17 PM | 1 NOV 2024
    13.45 (5.01%)

    Jubilant Pharmova share price

    1,273.00
    06:59 PM | 1 NOV 2024
    60.65 (5%)
    More from Top Gainers

    Recommended For You

      More Recommendations

      Gold Prices

      • 24K
      • 22K
      Bangalore
      80,565.000.00
      Chennai
      80,571.000.00
      Delhi
      80,723.000.00
      Kolkata
      80,575.000.00

      Fuel Price

      • Petrol
      • Diesel
      Bangalore
      102.92/L0.00
      Chennai
      101.23/L0.00
      Kolkata
      104.95/L0.00
      New Delhi
      94.77/L0.00

      Popular in Companies

        HomeMarketsloanPremiumMint Shorts